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The aim of the present study was to evaluate the frequency of detection of Mogibacterium timidum in 
subgingival samples of subjects with generalized aggressive periodontitis (GAgP) and uncontrolled diabetic 
and non-diabetic subjects with generalized chronic periodontitis (GChP). 48 patients with GAgP, 50 non-
diabetic and 39 uncontrolled (glycated hemoglobin >7%) type 2 diabetic subjects with GChP were enrolled 
in this study. Subgingival biofilm were collected from deep pockets (probing depth > 7 mm). After DNA 
extraction, M. timidum was detected by Nested Polymerase Chain Reaction and chi-square test was used to 
data analysis (p>0.05). There were no differences in the frequency of detection of M. timidum between 
subjects with GAgP (35%) and non-diabetic subjects with GChP (40%) (p>0.05). The frequency of 
detection of M. timidum was significantly higher in deep pockets of diabetic subjects with GChP (56%) 
when compared to GAgP (p<0.05), but similar to non-diabetic subjects with GChP (p>0.05). The frequency 
of detection of M. timidum was higher in subjects GChP presenting uncontrolled type 2 diabetes mellitus, 
when compared to GAgP subjects. 
 




In 2000, the new genus Mogibacterium was proposed to 
include the novel species Mogibacterium pumilum and 
Mogibacterium vescum, as well as the former Eubacterium 
timidum by taxonomic reassignment (16). Members of the 
genus Mogibacterium are described as strictly anaerobic and 
asaccharolytic Gram-positive rod-shaped bacteria. Cells are 
non-motile, do not form spores and exhibit very poor growth in 
broth media. Mogibacterium timidum (formerly Eubacterium 
timidum (9)), nominated due to its slight or slow growth in 
clumps, is an example of this genera that are regular to slightly 
diphtheroid in shape. This bacterium has shown to be present 
in oral environments and to be involved in infectious oral
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M. timidum was previously isolated from subgingival 
biofilm of periodontitis (9). In addition, detection of M. 
timidum increased as the severity of the clinical parameters of 
gingivitis increased (14), suggesting that this species could 
contribute to the increased susceptibility of adults to gingivitis 
and periodontitis. Subsequently, Moore et al. (13) 
demonstrated the presence of M. timidum periodontal pockets 
of “juvenile” and chronic periodontitis (CP). Moreover, M. 
timidum was also correlated to other forms of head and neck 
infections. Hill et al. (8) evaluated the microbial biodiversity of 
head and neck abscesses (Ludwig’s angina) and acute lung and 
liver infections using culture and biochemical techniques, and 
identified M. timidum in many of the infected sites. 
Although M. timidum has been shown to play an 
important role in periodontal disease, no study as of yet has 
compared the frequency of the detection of this bacterium 
between chronic and aggressive periodontitis (AgP). In 
addition, the levels of M. timidum in CP diabetic subjects, 
which present an increased risk for periodontitis and other 
infections (12), have not been previously evaluated. Diabetes 
mellitus (DM) and poor glycemic control are considered 
important risk factors for periodontitis and have exhibited a 
negative influence on subgingival microbiota (4,10). Therefore, 
the aim of this study was to evaluate the frequency of detection 
of M. timidum in subgingival samples of subjects with 
aggressive periodontitis (AgP) and uncontrolled type 2 diabetic 
and non-diabetic subjects with chronic periodontitis (ChP). 
 
MATERIALS AND METHODS 
 
Study population  
Non-diabetic patients presenting generalized GAgP 
(n=48) and generalized GChP (n=50) were selected from 
population referred to Periodontal Clinic at Piracicaba Dental 
School, from December 2004 until February 2009. 39 subjects 
presenting GChP and type 2 DM for at least the past 5 years 
were selected from the population referred to the Periodontal 
Clinic at Guarulhos University, from July 2007 until January 
2008. All eligible subjects were thoroughly informed of the 
nature, potential risks and benefits of their participation in the 
study and signed their informed consent.  
GAgP and GChP were diagnosed based on the periodontal 
classification of the American Academy of Periodontology (1). 
Subjects had at least 15 teeth and needed to meet the following 
criteria in order to be included in this study: 
GAgP:  
‐ At least six permanent incisors and/or first molars 
with at least one site each with probing depth (PD) 
and clinical attachment level (CAL) > 4 mm and 
bleeding on probing (BoP);  
‐ At least of three teeth other than first molars and 
incisors with at least one site each with PD and 
CAL > 4 mm and BoP 
‐ At least 2 sites with PD and CAL ≥ 7 mm and BoP; 
‐ Good general health; 
‐ < 35 years old; 
GChP (diabetic and non-diabetic) 
‐ > 35 years old; 
‐ At least 30% of the sites with PD and clinical 
attachment level (CAL) > 4 mm and BoP.  
‐ At least 2 sites with PD and CAL ≥ 7 mm and 
BoP; 
Exclusion criteria for all groups were pregnancy, 
lactation, current smoking and smoking within the past 5 years, 
periodontal or/and antibiotic therapies in the previous 6 
months, use of mouthrinse containing antimicrobials in the 
preceding 3 months, any systemic condition (except DM) that 
could affect the progression of periodontal disease (e.g. 
immunological disorders) and long-term administration of anti-
inflammatory and immunosuppressive medications. Subjects 
with periapical pathology, orthodontic appliances and multiple 
systemic complications of DM were also excluded from the 
study.
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Glycemic status  
A single laboratory (Clinical Analysis Laboratory, 
Guarulhos University) performed the glycated hemoglobin 
(HbA1c) monitoring of the diabetic subjects. HbA1c (%) was 
measured by high-performance liquid chromatography. Poorly-
controlled diabetic subjects who had HbA1c values > 7% were 
included in the present study. 
 
Clinical parameters  
The following parameters were assessed at six sites of all 
teeth, excluding third molars (mesio-buccal, medio-buccal, 
disto-buccal, mesio-lingual, medio-lingual, disto-lingual), 
using a manual periodontal probe (UNC15, Hu-Friedy, 
Chicago, IL, USA): plaque index (PI), BoP, suppuration 
(SUP), PD (mm) and CAL (mm).  
 
Experimental groups  
Based on their glycemic and periodontal characteristics, 
the subjects were divided into one of the following groups: 
GAgP (n=48), non-diabetic with GChP (50) and poorly 
controlled type 2 diabetic subjects with GChP (n=39) 
 
M. timidum detection 
Subgingival biofilm were collected from 2 deep pockets 
(PD > 7mm) per subject using a Gracey curette. Prior to 
sampling, supragingival plaque was removed with sterile 
cotton pellets and the sites were isolated with cotton rolls to 
avoid saliva contamination. DNA was extracted as previously 
described by Saito et al. (18). After DNA extraction, the 
presence of M. timidum was determined by a Nested 
Polymerase Chain Reaction (Nested PCR). The outer and inner 
primers were based on Mayanagi et al.  (11). PCR products 
were then loaded on a 1% agarose gel stained with ethidium 
bromide and amplicons were detected under UV light. 
 
Statistical Analysis 
Demographic and clinical comparisons were performed 
by one way ANOVA. When there were significant differences 
by one way ANOVA, a pairwise comparison was performed 
by Tukey test. Gender distribution and M. timidum frequencies 
were compared using Chi-Square test. The level of 




Clinical and demographic results 
Table 1 shows the demographic and clinical 
characteristics of study population according to periodontal and 
systemic diagnosis. No differences between groups were 
observed in all clinical parameters or gender distribution. 
GAgP subjects were younger (27.6 ± 0.9 years) than non-
diabetic (43.6±8.3 years) and diabetic subjects with GChP 
(56.5 ± 9.5 years). Hb1Ac levels in diabetic group was 10.4 ± 
2.6% 
 
Table 1. Demographic characteristics of the study population and full-mouth clinical parameters (mean ± SD). 
 GAgP Non-diabetic with GChP Type 2 diabetic with GChP 
Age 27.6±0.9 a 43.6 ± 8.3 b 56.4 ± 9.5 b 
Gender (M/F) 13/35 16/34 21/22 
PI (%) 55.4 ± 18,5 69.8 ± 33.7 76.5 ± 30.6 
BoP (%) 39.5 ± 29.8 52.3 ± 34.6 54.1 ± 33.7 
PD (mm) 3.3 ± 4.6 3.8 ± 4.5 3.6 ± 4.4 
CAL (mm) 4.1 ± 1.0 4.4 ± 1.1 4.4 ± 0.9 
Hb1Ac - - 10.4 ± 2.6 
Different letters indicate statistical differences among groups (one way-ANOVA/Tukey;  p<0.05). SD – Standard Deviation 
 
 934
Casarin, R.C.V. et al.                      M. timidum in subgingival biofilm 
 
 
M. timidum detection results  
Figure 1 presents the frequency of detection of M. 
timidum among groups. There were no differences in the 
frequency of detection of M. timidium between non-diabetic 
subjects with GChP and GAgP and type 2 diabetic subjects 
with GChP (p>0.05). However, diabetic subjects with GChP 
presented higher frequency of detection of M. timidium when 
compared to GAgP (p<0.05). M. timidum was detected in 35% 
of subjects diagnosed with GAgP, while in 40% of the non-
diabetic subjects with GChP harbored by this bacterium 
(p>0.05). GChP subjects presenting uncontrolled DM showed 
the highest detection frequency of M. timidum (56%) 
No correlation to glycemic control was observed, with no 
relationship between presence of M. timidum and HbAc1 level 
(data no show).  
 
 
Figure 1. Frequency of M. timidumdetection in all experimental groups (Chi-square test, p<0.05). GAgP: generalized aggressive 





M. timidum has been described as an oral pathogen, 
usually detected in the subgingival environment and related to 
the severity of periodontal breakdown. Since there are no 
studies comparing the levels of M. timidum among different 
types of periodontitis and groups at risk for periodontitis, this 
study evaluated for the first time the frequency of detection of 
this species on subgingival samples from GAgP and ChP, 
associated and not associated with DM. Overall, our results 
confirm that deep periodontal pockets may shelter M. timidium, 
independent of the type of periodontitis. In addition, the 
present findings show that the frequency of M. timidium was 
similar between GAgP and GChP, but significantly increased 
when the GChP was associated with DM with poor glycemic 
control. Together, these data suggest that M. timidum may be 
associated with periodontitis and that GChP subjects under the 
challenge of hyperglycemia may be at increased risk for M. 
timidium colonization in deep pockets.  
Several microbiological techniques have been used to 
identify M. timidum in different oral samples. By means of the 
PCR with species-specific oligonucleotides, M. timidum has 
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been detected in endodontic infections (7), periodontitis (11) 
and other head and neck infection foci (3). Other techniques 
have been also applied, such as checkerboard DNA-DNA 
hybridization and 16S rDNA clone library analysis with broad 
detection primers. In the present study, nested PCR was used 
for the detection of M. timidum in several samples from deep 
periodontal pockets, which is a modification of conventional 
PCR able to reduce the contamination of products due to the 
amplification of unexpected primer binding sites. 
In 1980, Holdeman et al. (9) were the first to demonstrate 
the presence of M. timidum in periodontal pockets. After that, 
Moore et al. (13-15), in sequential studies, also determined the 
potential associations between M. timidum and periodontal 
disease. In their first study, the detection rates of such a species 
in periodontal pockets from ChP patients (formerly adult 
periodontitis) were 70% among the affected population (14). In 
addition, the abovementioned research group has also used the 
experimentally-induced gingivitis model, in which the 
prevalence of this microorganism was superior in adults than in 
youngsters (9 and 3%, respectively). Interestingly, M. timidum 
detection frequencies increased as the severity of the clinical 
parameters for gingivitis worsened (14). The authors suggested 
that M. timidum could contribute to adults’ increased 
susceptibility to experimental gingivitis and to periodontitis. 
Later, Moore et al. (13) also detected M. timidum in juvenile 
periodontitis (now AgP). The frequencies of M. timidum 
detection were 58%, 70% and 11% for AgP, severe ChP and 
periodontally-healthy subjects, respectively. These results 
corroborate the findings of the present study, in which the 
levels of detection of M. timidum in AgP were also modestly 
less pronounced than in ChP (35 versus 40%, respectively). 
However, differences in the frequencies of M. timidium 
detection between the work of Moore et al. and the present 
study may be attributed to differences in the characteristics of 
the studies’ populations, periodontal disease severity and 
microbiological techniques.  
In the last decade, the role of M. timidum on periodontitis 
etiology has been investigated by a series of studies. In 2004, 
Booth et al. (2) detected M. timidum in shallow pockets of ChP 
patients by means of a non-cultivable technique (slot-blot 
hybridization). However, since the detection limit of this 
methodology was approximately 104 bacteria, the authors 
stated that their results should be carefully considered. 
Mayanagi et al. (11) evaluated the presence of M. timidum in 
sub- and supragingival biofilm from periodontitis patients and 
healthy individuals. Patients with periodontal disease presented 
high detection rates of M. timidium in comparison to healthy 
individuals. In supragingival biofilm, whilst only 15% of 
healthy individuals presented M. timidum, the species was 
detected in 65% of periodontitis patients. In addition, 10% and 
70% of the subgingival biofilm from healthy and periodontitis 
patients, respectively, were infected with M. timidum. 
Recently, Colombo et al. (5), using a microarray methodology, 
revealed that periodontitis patients harboring higher amounts of 
M. timidum displayed a refractory type of periodontitis, 
resulting in lower gain of clinical attachment levels. In general, 
in agreement with the present results, all of these studies 
produced evidence that M. timidum may be an important 
pathogen in periodontitis.  
Besides the confirmatory findings of the presence of M. 
timidum in periodontal pockets, the results of the present study 
contributed to the original information available regarding the 
increased colonization of M. timidum in periodontal pockets of 
diabetic subjects with GChP. We found that diabetic 
individuals with poor glycemic control presented the highest 
frequency of M. timidum detection. In fact, DM is a well-
established risk factor for periodontitis, and an altered immune-
inflammatory response seems to be the primary mechanism 
that could explain the increased severity and progression of 
periodontitis in diabetic subjects (12). Moreover, poorly 
controlled diabetic subjects, presenting elevated levels of 
HbA1c, show higher attachment and alveolar bone loss and 
exacerbated local inflammation when compared to well-
controlled ones (6,17). In addition to the poorer inflammatory 
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immune response against pathogens, the subgingival microbial 
profile could also be a possible explanation for the increased 
risk of periodontitis in diabetic subjects. Intensified local 
inflammation in diabetic subjects with inadequate glycemic 
control could modify the subgingival environment and, 
consequently, the subgingival microbial profile. Recently, our 
research group has demonstrated that glycemic control 
positively correlates with the herpes virus colonization in 
periodontal pockets (4). In addition, Makiura et al. (10) showed 
that Porphyromonas gingivalis was detected more frequently in 
subjects with increased HbA1c values after periodontal 
treatment than in those patients with reduced HbA1c values.  
Therefore, the study of specific microorganisms—such as 
M. timidum in the subgingival biofilm of groups susceptible to 
periodontitis, including diabetic subjects—seems to be 
important to improving knowledge about the relationship 
between DM and severe periodontitis development. Moreover, 
it is important attempt to the relatively low detection of M. 
timidum in periodontal sites. In all three groups included in this 
study, this bacterium was detected in approximately half of 
periodontal sites (although in diabetic subjects this frequency 
was higher than GAgP). However, it should be considered that 
more than 400 species are enrolled in periodontal disease and 
different biofilm composition has been associated to different 
conditions, for example, smokers, diabetics and systemic 
disorders. This way, different species could influence 
periodontal tissues destruction and, considering the results of 
the present study, M. timidum should be considered in future 
analysis. Therefore, considering that subgingival biofilm was 
collected from deep pockets of patients presenting generalized 
and severe periodontal destruction, and that M. timidum is 
almost absent in health sites, it could indicate the important 
role of M. timidum in sites exhibiting periodontal breakdown 
and could be enrolled in progression of disease in some cases. 
With this in mind, future studies should consider the 
significance of these results and identify the pathogenic 
pathway with which M. timidum could be associated. Thus, the 
next step to consider in future analysis is the virulence factors 
and pathogen-associated molecular patterns of this species, 
determining its real role in periodontal breakdown and 
identifying a therapeutic protocol to control its infection. 
Altogether, considering its possible virulence factors and its 
high prevalence in periodontitis biofilm, M. timidum harbors 
high potential to initiate and/or to increase the inflammatory 
response in periodontal tissues, especially in patients 




M. timidum was highly prevalent in both GAgP and 
GChP, but its prevalence was considerably increased when the 
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